Postpartum Pelvic Floor Dysfunction
Conditions
Interventions
Sequential Magnetic-Electrical Therapy Group:Completed 10 sessions each of magnetic stimulation and electrical stimulation in three phases (magnetic ? magnetic-electric transition ? electrical)
Combined Magnetic-Electrical Therapy Group:Received simultaneous magnetic and electrical stimulation during each session, completing 10 sessions of each
Electrical Therapy Only Group:Electrical stimulation therapy administered exclusively, totaling 10 sessions
Sponsors
Shulan (Hangzhou) Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1.Primiparous or multiparous women aged 20–40 years who delivered vaginally, between 42 days postpartum and 3 months postpartum, with singleton full-term delivery (>=37 weeks); 2.At least one of the following diagnostic criteria for pelvic floor dysfunction is present: (1)Maximum contraction potential 20cm² or bladder neck mobility >25mm; (3) Urinary incontinence (ICI-Q-SF score>=1 point); 3.Informed Consent: Voluntarily sign the informed consent form and complete the follow-up plan.
Exclusion criteria
Exclusion criteria: 1.Pregnancy-related contraindications: Multiple pregnancies, history of forceps delivery, third- or fourth-degree perineal lacerations; 2.Systemic diseases: Severe cardiac, hepatic, or renal disease; diabetes mellitus; neurological disorders; 3.Therapeutic contraindications: History of pelvic floor surgery; presence of metallic implants or cardiac pacemakers; 4.Interfering factors: Use of estrogen-based medications within the past three months; participation in other pelvic floor rehabilitation programs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pelvic Floor Ultrasound (Cystocervical mobility, area of the genital hiatus, posterior bladder-urethral angle, urethral rotation angle);Pelvic Floor Electromyographic Parameters (Pre-resting potential, post-resting potential, maximum contraction potential of fast-twitch fibers, endurance potential of slow-twitch fibers);Serum osteopontin (OPN), Matrix metalloproteinase-2 (MMP-2); | — |
Secondary
| Measure | Time frame |
|---|---|
| Vaginal laxity questionnaire (VLQ), International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF), Female Sexual Function Index (FSFI);Cost-effectiveness ratio(CER); | — |
Countries
China
Contacts
Public ContactYan Guanghan
Shulan (Hangzhou) Hospital
Outcome results
None listed